REFERENCES
- Schuman J S, Orellana J, Friedman A H, Teich S A. Acquired immunodeficiency syndrome (AIDS). Surv Ophthalmol 1987; 31: 384–410
- Jabs D A, Van Natta M L, Kempen J H, et al. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 2002; 133: 48–61
- Jacobson M A, Stanley H, Holtzer C, Margolis T P, Cunningham E T. Natural history and outcomes of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30: 231–233
- Plummer D J, Sample P A, Arevalo J F, et al. Visual field loss in HIV-positive patients without infectious retinopathy. Am J Ophthalmol 1996; 122: 542–549
- Quinceno J I, Capparelli E, Sadunn A A, et al. Visual dysfunction without retinopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1992; 113: 8–13
- Mueller A J, Plummer D J, Dua R, et al. Analysis of visual dysfunctions in HIV-positive patients without retinitis. Am J Ophthalmol 1997; 124: 158–167
- Latkany P A, Holopigian K, Lorenzo-Latkany M, Seiple M. Electroretinographic and psychophysical findings during early and late stages of human immunodeficiency virus infection and cytomegalovirus retinitis. Ophthalmology 1997; 104: 445–453
- Freeman W R, Chen A, Henderly D A, et al. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol 1989; 15: 229–235
- El Beltagi T A, Bowd C, Boden C, et al. Retinal nerve fiber layer thickness measured with optical coherence tomography is related to visual function in glaucomatous eyes. Ophthalmology 2003; 110: 2185–2191
- Jaffe G H, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol 2004; 137: 156–159
- Huang D, Swanson E A, Lin C P, et al. Optical coherence tomography. Science 1991; 254: 1178–1181
- Hee M R, Izatt J A, Swanson E A, et al. Optical coherence tomography of the human retina. Arch Ophthalmol 1995; 124: 325–332
- Schuman J S, Pedut-Kloizman T, Hertzmark E, et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology 1996; 103: 1189–1198
- Koozekanani D, Roberts C, Katz S E, Herderick E E. Intersession repeatability of macular thickness measurements using the Humphrey 2000 OCT. Invest Ophthalmol Vis Sci 2000; 41: 1486–1491
- Schuman J S, Hee M R, Puliafito C A, et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol 1995; 113: 586–596
- Bowd C, Weinreb R N, Williams J M, Zangwill L M. The retinal nerve fiber layer thickness in ocular hypertensive, normal and glaucomatous eyes with optical coherence tomography. Arch Ophthalmol 2000; 118: 22–26
- Kozak I, Bartsch D U, Cheng L, Kosobucki B, Freeman W R. Objective analysis of retinal damage in HIV-positive patients in the HAART era using OCT. Am J Ophthalmol 2005; 139: 295–301
- Liu X, Ling Y, Luo R, Ge J, Zheng X. Optical coherence tomography in measuring retinal nerve fiber layer thickness in normal subjects and patient with open-angle glaucoma. Clin Med J 2001; 114: 524–529
- Varma R, Bazzaz S, Lai M. Optical tomography-measured retinal nerve fiber layer thickness in normal Latinos. Invest Ophthalmol Vis Sci. 2003; 44: 3369–3373
- Varma R, Skaf M, Barron E. Retinal nerve fiber layer thickness in normal eyes. Ophthalmology 1998; 103: 2114–2119
- Mansour A M, Jampol L M, Logani S, Read J, Henderly D. Cotton wool spots in acquired immunodeficiency syndrome compared with diabetes mellitus, systemic hypertension, and central retinal vein occlusion. Arch Ophthalmol 1998; 106: 1074–1077
- Sample P A, Plummer D J, Mueller A J, et al. Pattern of early visual field loss in HIV-infected patients. Arch Ophthalmol 1999; 117: 755–760